Have you heard that the 5-year survival rate for pancreatic cancer increased? The American Cancer Society released their Cancer Facts & Figures, reporting that the 5-year survival rate for pancreatic cancer increased from 11% to 12%.

For the first time since 2017, the survival rate has increased for 2 years in a row. This promising trend points to continued progress in the fight against pancreatic cancer. It also means more loved ones will make it to 5 years after their diagnosis. Still, much work remains to be done.

Even as we celebrate this progress, we know there is so much more to be done. We will continue taking bold action to increase the survival rate for pancreatic cancer. At TrovaNow, we are up for the challenge. Together we fight. For our family. For our friends. For the future. For all.

The mission is to facilitate collaboration between the scientific community, the leading experts in pancreatic cancer, and industry to improve early detection, screening, risk modeling and prevention for those with a heritable risk for pancreatic cancer. Over 39 of the world’s leading medical centers are now working together as part of this collaborative effort known as the PRECEDE Consortium.

TrovaNow is the non-profit charitable organization that is dedicated to raising funds for PRECEDE.  Together with representation from the pharmaceutical, biotech, imaging, AI/machine learning, genetics and molecular diagnostics industries, TrovaNow is working to foster the exchange of ideas and information that will help us achieve our common goal of an increase in the 5-year survival rate for pancreatic cancer from 10% (Now increased to 12%) to 50% in the next 10 years. PRECEDE has assembled the largest high-risk patient cohort, with biospecimen collection and longitudinal clinical data that will be used to accelerate the development of new approaches to early detection and prevention of pancreatic cancer.

Continue this fight with us by making a donation to TrovaNOW today and help advance the early detection of pancreatic cancer and save lives. Your support keeps pancreatic cancer research going. Contributions go towards:⁣

• Maximizing identification of high risk individuals + advance early detection research and clinical care⁣.
• Developing and validating an early detection blood test for pancreatic cancer.⁣
• Advancing the understanding of genetics to pancreatic cancer risk and development, including finding new pancreatic cancer susceptibility genes.⁣
• Formulating and executing a strategic plan for pancreatic cancer prevention. ⁣

There is no simple screening test or other early detection tool for the disease, and its earliest symptoms are non-specific. Early detection and prevention would dramatically change the trajectory of pancreatic cancer, saving tens of thousands of lives each year.

Hope for the future starts with you. With more research and funding, fewer lives will be taken. Join us in our mission to advance the detection and treatment of pancreatic cancer to transform the landscape of this disease and improve survival rates.

With your donation, we’ll take bold action to improve the lives of everyone impacted by pancreatic cancer by advancing scientific research, building community, sharing knowledge, and advocating for patients.

If you have any questions or If you want more information about how to donate, just email us at trovanow@gmail.com or learn more at http://trovanow.com